Table I.
Cell viability, % | |||
---|---|---|---|
|
|||
Compound name | 20 μM OVCAR-3 | 40 μM OVCAR-3 | Mean |
(−)-epicatechin | 118.00±1.15a | 127.01±3.79a | 122.50a |
(+)-catechin hydrate | 119.67±1.33a | 123.33±1.20a | 121.50a |
Ellagic acid | 121.67±1.45a | 119.67±2.85a | 120.67a |
Tangeretin | 88.80±1.54b | 76.90±2.29b | 82.85b |
Nobiletin | 79.93±4.75b,c | 71.47±5.81b | 75.70b |
Baicalin | 88.13±2.56b | 53.37±5.98c | 70.75b |
Baicalein | 72.20±5.34c,d | 23.80±4.40d | 48.00c |
Gallic acid | 64.53±6.72d | 2.43±0.34e | 33.48c |
Cisplatin | 19.77±1.52e | 6.02±0.37e | 12.89d |
Data are presented as the mean ± standard error of the mean from three independent experiment. Values marked with different letters are significantly different (at P<0.05) when compared with each other.